about
Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in PatientsMechanisms of viral mutationA step forward understanding HIV-1 diversitySurvivors Remorse: antibody-mediated protection against HIV-1.The global spread of HIV-1 subtype B epidemic.PASS-based approach to predict HIV-1 reverse transcriptase resistance.In vivo mutation rates and the landscape of fitness costs of HIV-1.The Membrane-Proximal Region of C-C Chemokine Receptor Type 5 Participates in the Infection of HIV-1.Recent advances in understanding HIV evolutionCellular Defense Enzyme Drives Exceptionally High Rate of Mutation in HIV.Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia.Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation.The Mutational Robustness of Influenza A Virus.Patterns of amino acid conservation in human and animal immunodeficiency viruses.Identification of HIV Mutation as Diagnostic Biomarker through Next Generation Sequencing.A Single Nucleotide Polymorphism in Human APOBEC3C Enhances Restriction of LentivirusesExperimental Estimation of the Effects of All Amino-Acid Mutations to HIV's Envelope Protein on Viral Replication in Cell CultureEffect of the Latent Reservoir on the Evolution of HIV at the Within- and Between-Host Levels.HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant IntegrasesBuffering deleterious polymorphisms in highly constrained parts of HIV-1 envelope by flexible regions.Inhibitors of Deubiquitinating Enzymes Block HIV-1 Replication and Augment the Presentation of Gag-Derived MHC-I Epitopes.Issues in vaccinology: Present challenges and future directions.A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses.Reassessing APOBEC3G Inhibition by HIV-1 Vif-Derived Peptides.On the importance of skewed offspring distributions and background selection in virus population genetics.The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence.Fight fire with fire: Gene therapy strategies to cure HIV.Highly heterogeneous mutation rates in the hepatitis C virus genome.Different rates of spontaneous mutation of chloroplastic and nuclear viroids as determined by high-fidelity ultra-deep sequencing.Modulation of the strength and character of HIV-specific CD8+ T cell responses with heteroclitic peptides.The mutable vaccine for mutable viruses.Mechanism of Anti-rotavirus Synergistic Activity by Epigallocatechin Gallate and a Proanthocyanidin-Containing Nutraceutical.The not-so-infinite malleability of RNA viruses: Viral and cellular determinants of RNA virus mutation rates.High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide.Antigenic Variation and Immune Escape in the MTBC.Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses.What do docking and QSAR tell us about the design of HIV-1 reverse transcriptase nonnucleoside inhibitors?Modern methods for laboratory diversification of biomolecules.
P2860
Q27468616-58B5F6CE-871E-4522-B3A6-9DE42FB5F806Q28067235-984DFEE9-3A37-4A61-8275-95CCC85D20E8Q28073626-6B50ACF8-A200-4B19-95AB-BBC7C1FDF213Q30238730-48360F97-9289-4DE3-9F71-A532F5488D1BQ30388926-E63AFEF2-FEA2-4162-BB1E-B052ECD0F7D7Q30490600-AEBEBA1F-DA35-40FA-94C3-5333528F5D65Q33589204-292C4D65-8C37-4390-9EF1-928FB69D1333Q33595068-5FCB4769-7027-48E5-99AE-2CDEA24CC4BBQ33631993-14FFAE01-6480-46A6-BA8B-F5F8B0CC1A28Q35777199-E571694E-702F-4006-A410-E7AFB93B7C56Q35945852-04CFB0EF-C134-42F2-B1BB-B2D1F26CFDB7Q36019742-5D145BB9-6255-4341-B6F7-6A0D615CBBB5Q36116006-8AD99276-BFC7-4C53-9A9B-C6C1C1C90B0AQ36121160-ED144A4C-3E73-4D7A-AC61-789BD909C422Q36133597-32A0E044-EC61-46FA-9AC9-B149EE2A82A2Q36161563-D23485E5-93E3-46EF-8BAD-72B9C107EFD8Q36222292-CBDEE1B0-FD6B-4F5A-9612-C364D7F06787Q36253793-ED31AD36-5C20-4C55-A586-542D32EB602BQ36812121-A6C352ED-97C4-42AA-B466-07E21E634ADAQ37139889-E09870F1-0ABD-46A5-A287-7C3737E0EC53Q38626145-3E129618-03CD-43B7-BEFD-061EF2144B07Q38634551-00D9010C-19E8-4C6D-A1C6-CD9107B9B084Q38734385-A4264C7C-85A6-4B6A-A4B7-C3F69D02BC85Q38790689-060BDE95-0DEA-4ABC-8BAB-847F6AF1402CQ38819403-67345044-407F-4FE5-B371-73DD0E189392Q38887465-454426B7-96A7-4478-B475-79862E3577DAQ39425614-7A68C24A-DA73-4C2A-91BF-3C29A3542C00Q39442707-0D30942A-D84F-4D9D-9F73-9BFD4F25104AQ40041222-852CF500-9B10-4327-8CD8-D8B04E2E518CQ40047262-7C2BA31D-72C2-4065-93A9-6FFE609D2255Q40144203-B7B660AA-1476-49F5-B54E-9F3FDFD215CFQ40217730-0DFE4440-1B68-40D5-BFA1-BB64EBD67F3FQ40225361-4ECAD646-B7EA-416F-A275-A91DEDF6A064Q40548483-0565355D-5E2F-4974-B94A-F49504364FC2Q40802197-2E788F8D-65F6-4F48-B88C-EC9FCC588018Q41191267-C8AFD6CF-5BB1-413E-838A-D27707C681D8Q47108789-0D200B59-6B87-4C7E-A5D6-3DCEFEDEF55DQ47120902-BC21F3B9-A273-4451-83C2-5799E2D1D62FQ47136053-343E01D7-AA67-4CC1-B0B5-617F755EC16FQ47387337-A9CC99ED-1744-4537-B50D-9044A02AF625
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Extremely High Mutation Rate of HIV-1 In Vivo
@ast
Extremely High Mutation Rate of HIV-1 In Vivo
@en
Extremely High Mutation Rate of HIV-1 In Vivo
@nl
type
label
Extremely High Mutation Rate of HIV-1 In Vivo
@ast
Extremely High Mutation Rate of HIV-1 In Vivo
@en
Extremely High Mutation Rate of HIV-1 In Vivo
@nl
prefLabel
Extremely High Mutation Rate of HIV-1 In Vivo
@ast
Extremely High Mutation Rate of HIV-1 In Vivo
@en
Extremely High Mutation Rate of HIV-1 In Vivo
@nl
P2093
P2860
P3181
P1433
P1476
Extremely High Mutation Rate of HIV-1 In Vivo
@en
P2093
José López-Aldeguer
Rafael Sanjuán
Raquel Garijo
P2860
P304
P3181
P356
10.1371/JOURNAL.PBIO.1002251
P407
P577
2015-09-16T00:00:00Z